This Week in Biotech #51 (May 2–10, 2025)
CRISPR’s cholesterol breakthrough, the FDA’s new CBER chief rattles markets, NIH faces historic budget cuts, and Charles River pivots as animal testing falls out of favor. Plus: Gilead, Vertex, and key approvals you might’ve missed.

📺 This is a short weekly recap video, perfect for staying current in just a few minutes.

Subscribe to our FREE newsletter on biotechblueprint.substack.com